A differential association of Apolipoprotein E isoforms with the amyloid-β oligomer in solution

Jitka Petrlova, Hyun Seok Hong, Daniel A. Bricarello, Ghimire Harishchandra, Gary A. Lorigan, Lee-Way Jin, John C Voss

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

The molecular pathogenesis of disorders arising from protein misfolding and aggregation is difficult to elucidate, involving a complex ensemble of intermediates, whose toxicity depends upon their state of progression along distinct processing pathways. To address the complex misfolding and aggregation that initiates the toxic cascade resulting in Alzheimer's disease (AD), we have developed a 2,2,6,6-tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid spin-labeled amyloid-β (Aβ) peptide to observe its isoform-dependent interaction with the apoE protein. Although most individuals carry the E3 isoform of apoE, ~15% of humans carry the E4 isoform, which is recognized as the most significant genetic determinant for Alzheimer's. ApoE is consistently associated with the amyloid plaque marker for AD. A vital question centers on the influence of the two predominant isoforms, E3 and E4, on Aβ peptide processing and hence Aβ toxicity. We used electron paramagnetic resonance (EPR) spectroscopy of incorporated spin labels to investigate the interaction of apoE with the toxic oligomeric species of Aβ in solution. EPR spectra of the spin-labeled side chain report on side chain and backbone dynamics as well as the spatial proximity of spins in an assembly. Our results indicate oligomer binding involves the C-terminal domain of apoE, with apoE3 reporting a much greater response through this conformational marker. Coupled with SPR binding measurements, apoE3 displays a higher affinity and capacity for the toxic Aβ oligomer. These findings support the hypothesis that apoE polymorphism and Alzheimer's risk can largely be attributed to the reduced ability of apoE4 to function as a clearance vehicle for the toxic form of Aβ.

Original languageEnglish (US)
Pages (from-to)402-416
Number of pages15
JournalProteins: Structure, Function and Bioinformatics
Volume79
Issue number2
DOIs
StatePublished - Feb 2011

Fingerprint

Apolipoproteins E
Oligomers
Amyloid
Protein Isoforms
Poisons
Apolipoprotein E3
Electron Spin Resonance Spectroscopy
Paramagnetic resonance
Toxicity
Alzheimer Disease
Agglomeration
Proteostasis Deficiencies
Apolipoprotein E4
Spin Labels
Peptides
Aptitude
Amyloid Plaques
Processing
Carboxylic Acids
Polymorphism

Keywords

  • Alzheimer's disease
  • Amyloid β-peptide
  • ApoE isoforms
  • Apolipoprotein E
  • EPR spectroscopy
  • TOAC spin label

ASJC Scopus subject areas

  • Biochemistry
  • Structural Biology
  • Molecular Biology

Cite this

A differential association of Apolipoprotein E isoforms with the amyloid-β oligomer in solution. / Petrlova, Jitka; Hong, Hyun Seok; Bricarello, Daniel A.; Harishchandra, Ghimire; Lorigan, Gary A.; Jin, Lee-Way; Voss, John C.

In: Proteins: Structure, Function and Bioinformatics, Vol. 79, No. 2, 02.2011, p. 402-416.

Research output: Contribution to journalArticle

Petrlova, Jitka ; Hong, Hyun Seok ; Bricarello, Daniel A. ; Harishchandra, Ghimire ; Lorigan, Gary A. ; Jin, Lee-Way ; Voss, John C. / A differential association of Apolipoprotein E isoforms with the amyloid-β oligomer in solution. In: Proteins: Structure, Function and Bioinformatics. 2011 ; Vol. 79, No. 2. pp. 402-416.
@article{61c87f6dd90f40ccb86ebb978720f52a,
title = "A differential association of Apolipoprotein E isoforms with the amyloid-β oligomer in solution",
abstract = "The molecular pathogenesis of disorders arising from protein misfolding and aggregation is difficult to elucidate, involving a complex ensemble of intermediates, whose toxicity depends upon their state of progression along distinct processing pathways. To address the complex misfolding and aggregation that initiates the toxic cascade resulting in Alzheimer's disease (AD), we have developed a 2,2,6,6-tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid spin-labeled amyloid-β (Aβ) peptide to observe its isoform-dependent interaction with the apoE protein. Although most individuals carry the E3 isoform of apoE, ~15{\%} of humans carry the E4 isoform, which is recognized as the most significant genetic determinant for Alzheimer's. ApoE is consistently associated with the amyloid plaque marker for AD. A vital question centers on the influence of the two predominant isoforms, E3 and E4, on Aβ peptide processing and hence Aβ toxicity. We used electron paramagnetic resonance (EPR) spectroscopy of incorporated spin labels to investigate the interaction of apoE with the toxic oligomeric species of Aβ in solution. EPR spectra of the spin-labeled side chain report on side chain and backbone dynamics as well as the spatial proximity of spins in an assembly. Our results indicate oligomer binding involves the C-terminal domain of apoE, with apoE3 reporting a much greater response through this conformational marker. Coupled with SPR binding measurements, apoE3 displays a higher affinity and capacity for the toxic Aβ oligomer. These findings support the hypothesis that apoE polymorphism and Alzheimer's risk can largely be attributed to the reduced ability of apoE4 to function as a clearance vehicle for the toxic form of Aβ.",
keywords = "Alzheimer's disease, Amyloid β-peptide, ApoE isoforms, Apolipoprotein E, EPR spectroscopy, TOAC spin label",
author = "Jitka Petrlova and Hong, {Hyun Seok} and Bricarello, {Daniel A.} and Ghimire Harishchandra and Lorigan, {Gary A.} and Lee-Way Jin and Voss, {John C}",
year = "2011",
month = "2",
doi = "10.1002/prot.22891",
language = "English (US)",
volume = "79",
pages = "402--416",
journal = "Proteins: Structure, Function and Bioinformatics",
issn = "0887-3585",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - A differential association of Apolipoprotein E isoforms with the amyloid-β oligomer in solution

AU - Petrlova, Jitka

AU - Hong, Hyun Seok

AU - Bricarello, Daniel A.

AU - Harishchandra, Ghimire

AU - Lorigan, Gary A.

AU - Jin, Lee-Way

AU - Voss, John C

PY - 2011/2

Y1 - 2011/2

N2 - The molecular pathogenesis of disorders arising from protein misfolding and aggregation is difficult to elucidate, involving a complex ensemble of intermediates, whose toxicity depends upon their state of progression along distinct processing pathways. To address the complex misfolding and aggregation that initiates the toxic cascade resulting in Alzheimer's disease (AD), we have developed a 2,2,6,6-tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid spin-labeled amyloid-β (Aβ) peptide to observe its isoform-dependent interaction with the apoE protein. Although most individuals carry the E3 isoform of apoE, ~15% of humans carry the E4 isoform, which is recognized as the most significant genetic determinant for Alzheimer's. ApoE is consistently associated with the amyloid plaque marker for AD. A vital question centers on the influence of the two predominant isoforms, E3 and E4, on Aβ peptide processing and hence Aβ toxicity. We used electron paramagnetic resonance (EPR) spectroscopy of incorporated spin labels to investigate the interaction of apoE with the toxic oligomeric species of Aβ in solution. EPR spectra of the spin-labeled side chain report on side chain and backbone dynamics as well as the spatial proximity of spins in an assembly. Our results indicate oligomer binding involves the C-terminal domain of apoE, with apoE3 reporting a much greater response through this conformational marker. Coupled with SPR binding measurements, apoE3 displays a higher affinity and capacity for the toxic Aβ oligomer. These findings support the hypothesis that apoE polymorphism and Alzheimer's risk can largely be attributed to the reduced ability of apoE4 to function as a clearance vehicle for the toxic form of Aβ.

AB - The molecular pathogenesis of disorders arising from protein misfolding and aggregation is difficult to elucidate, involving a complex ensemble of intermediates, whose toxicity depends upon their state of progression along distinct processing pathways. To address the complex misfolding and aggregation that initiates the toxic cascade resulting in Alzheimer's disease (AD), we have developed a 2,2,6,6-tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid spin-labeled amyloid-β (Aβ) peptide to observe its isoform-dependent interaction with the apoE protein. Although most individuals carry the E3 isoform of apoE, ~15% of humans carry the E4 isoform, which is recognized as the most significant genetic determinant for Alzheimer's. ApoE is consistently associated with the amyloid plaque marker for AD. A vital question centers on the influence of the two predominant isoforms, E3 and E4, on Aβ peptide processing and hence Aβ toxicity. We used electron paramagnetic resonance (EPR) spectroscopy of incorporated spin labels to investigate the interaction of apoE with the toxic oligomeric species of Aβ in solution. EPR spectra of the spin-labeled side chain report on side chain and backbone dynamics as well as the spatial proximity of spins in an assembly. Our results indicate oligomer binding involves the C-terminal domain of apoE, with apoE3 reporting a much greater response through this conformational marker. Coupled with SPR binding measurements, apoE3 displays a higher affinity and capacity for the toxic Aβ oligomer. These findings support the hypothesis that apoE polymorphism and Alzheimer's risk can largely be attributed to the reduced ability of apoE4 to function as a clearance vehicle for the toxic form of Aβ.

KW - Alzheimer's disease

KW - Amyloid β-peptide

KW - ApoE isoforms

KW - Apolipoprotein E

KW - EPR spectroscopy

KW - TOAC spin label

UR - http://www.scopus.com/inward/record.url?scp=78650792092&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650792092&partnerID=8YFLogxK

U2 - 10.1002/prot.22891

DO - 10.1002/prot.22891

M3 - Article

C2 - 21069870

AN - SCOPUS:78650792092

VL - 79

SP - 402

EP - 416

JO - Proteins: Structure, Function and Bioinformatics

JF - Proteins: Structure, Function and Bioinformatics

SN - 0887-3585

IS - 2

ER -